Cargando…
A retrospective analysis of eosinophilia as a predictive marker of response and toxicity to cancer immunotherapy
AIM: To investigate eosinophilia as a potential on-treatment biomarker for patients receiving cancer immunotherapy. MATERIALS & METHODS: We evaluated the association between eosinophilia and treatment response and toxicity in a retrospective cohort of patients receiving cancer immunotherapy. RES...
Autores principales: | Krishnan, Tharani, Tomita, Yoko, Roberts-Thomson, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720365/ https://www.ncbi.nlm.nih.gov/pubmed/33312694 http://dx.doi.org/10.2144/fsoa-2020-0070 |
Ejemplares similares
-
Tocilizumab: Toxic erythema and eosinophilia: case report
Publicado: (2020) -
Fenofibrate: Hepatotoxicity, pulmonary toxicity and eosinophilia: case report
Publicado: (2022) -
The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia
por: Duman, Dildar, et al.
Publicado: (2015) -
Eosinophilia and Response to Bronchial Thermoplasty
por: Svenningsen, Sarah, et al.
Publicado: (2021) -
The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [Corrigendum]
Publicado: (2016)